Search Results - "Um, Soon‐Ho"

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis by Ahn, Young Eun, Suh, Sang Jun, Yim, Hyung Joon, Seo, Yeon Seok, Yoon, Eileen L, Kim, Tae Hyung, Lee, Young Sun, Yim, Sun Young, Kim, Hae Rim, Kang, Seong Hee, Jung, Young Kul, Kim, Ji Hoon, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

“…Sorafenib is the first approved systemic treatment for advanced hepatocellular carcinoma (HCC). However, its clinical utility is limited, especially in Asian…”
Get full text

Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis by Lee, Han Ah, Jung, Joon Young, Lee, Young-Sun, Jung, Young Kul, Kim, Ji Hoon, An, Hyonggin, Yim, Hyung Joon, Jeen, Yoon Tae, Yeon, Jong Eun, Byun, Kwan Soo, Um, Soon Ho, Seo, Yeon Seok

“…Background/AimsMost prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study…”
Get full text

Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B by Kim, Tae Hyung, Kim, Ji Hoon, Yim, Hyung Joon, Seo, Yeon Seok, Yim, Sun Young, Lee, Young-Sun, Jung, Young Kul, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

“…: Besifovir dipivoxil maleate (BSV) and tenofovir alafenamide fumarate (TAF) have been recently approved in Korea as the initial antiviral agents for chronic…”
Get full text

Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma by Lee, Han Ah, Lee, Young-Sun, Kim, Beom Kyung, Jung, Young Kul, Kim, Seung Up, Park, Jun Yong, Kim, Ji Hoon, An, Hyunggin, Kim, Do Young, Yim, Hyung Joon, Ahn, Sang Hoon, Yeon, Jong Eun, Byun, Kwan Soo, Han, Kwang-Hyub, Um, Soon Ho, Seo, Yeon Seok

“…We investigated changes in recurrence rates and significant recurrence predictors over time after complete cure of hepatocellular carcinoma (HCC). A total of…”
Get full text

Antiviral activity and safety of LB80380 in hepatitis B e antigen–positive chronic hepatitis B patients with lamivudine‐resistant disease by Yuen, Man‐Fung, Han, Kwang‐Hyub, Um, Soon‐Ho, Yoon, Seung Kew, Kim, Hye‐Ryon, Kim, John, Kim, Chung Ryeol, Lai, Ching‐Lung

“…We aimed to determine the antiviral activity and safety of a new nucleotide analogue, LB80380, in chronic hepatitis B (CHB) patients with lamivudine‐resistant…”
Get full text

Twenty‐four‐week clevudine therapy showed potent and sustained antiviral activity in HBeAg‐positive chronic hepatitis B by Yoo, Byung Chul, Kim, Ju Hyun, Chung, Young‐Hwa, Lee, Kwan Sik, Paik, Seung Woon, Ryu, Soo Hyung, Han, Byung Hoon, Han, Joon‐Yeol, Byun, Kwan Soo, Cho, Mong, Lee, Heon‐Ju, Kim, Tae‐Hun, Cho, Se‐Hyun, Park, Joong‐Won, Um, Soon‐Ho, Hwang, Seong Gyu, Kim, Young Soo, Lee, Youn‐Jae, Chon, Chae Yoon, Kim, Byung‐Ik, Lee, Young‐Suk, Yang, Jin‐Mo, Kim, Haak Cheoul, Hwang, Jae Seok, Choi, Sung‐Kyu, Kweon, Young‐Oh, Jeong, Sook‐Hyang, Lee, Myung‐Seok, Choi, Jong‐Young, Kim, Dae‐Ghon, Kim, Yun Soo, Lee, Heon Young, Yoo, Kwon, Yoo, Hee‐Won, Lee, Hyo‐Suk

“…Clevudine is a pyrimidine analogue with potent and sustained antiviral activity against HBV. The present study evaluated the safety and efficacy of 30 mg…”
Get full text

Clevudine is highly efficacious in hepatitis B e antigen‐negative chronic hepatitis B with durable off‐therapy viral suppression by Yoo, Byung Chul, Kim, Ju Hyun, Kim, Tae‐Hun, Koh, Kwang Cheol, Um, Soon‐Ho, Kim, Young Soo, Lee, Kwan Sik, Han, Byung Hoon, Chon, Chae Yoon, Han, Joon‐Yeol, Ryu, Soo Hyung, Kim, Haak Cheoul, Byun, Kwan Soo, Hwang, Seong Gyu, Kim, Byung‐Ik, Cho, Mong, Yoo, Kwon, Lee, Heon‐Ju, Hwang, Jae Seok, Kim, Yun Soo, Lee, Young‐Suk, Choi, Sung‐Kyu, Lee, Youn‐Jae, Yang, Jin‐Mo, Park, Joong‐Won, Lee, Myung‐Seok, Kim, Dae‐Ghon, Chung, Young‐Hwa, Cho, Se‐Hyun, Choi, Jong‐Young, Kweon, Young‐Oh, Lee, Heon Young, Jeong, Sook‐Hyang, Yoo, Hee‐Won, Lee, Hyo‐Suk

“…Clevudine is a pyrimidine analog with potent and sustained antiviral activity against HBV. In the present study, we evaluated the safety and efficacy of…”
Get full text

A novel cleansing score system for capsule endoscopy by Park, Sung Chul, Keum, Bora, Hyun, Jong Jin, Seo, Yeon Seok, Kim, Yong Sik, Jeen, Yoon Tae, Chun, Hoon Jai, Um, Soon Ho, Kim, Chang Duck, Ryu, Ho Sang

“…AIM:To suggest a new cleansing score system for small bowel preparation and to evaluate its clinical efficacy.METHODS:Twenty capsule endoscopy cases were…”
Get full text

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B by Lee, Kwan Sik, Kweon, Young-Oh, Um, Soon-Ho, Kim, Byung-Ho, Lim, Young Suk, Paik, Seung Woon, Heo, Jeong, Lee, Heon-Ju, Kim, Dong Joon, Kim, Tae Hun, Lee, Young-Sok, Byun, Kwan Soo, Kim, Daeghon, Lee, Myung Seok, Yu, Kyungha, Suh, Dong Jin

“…Long-term data on antiviral therapy in Korean patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) are limited. This study evaluated…”
Get full text

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea by Kim, Seung Up, Seo, Yeon Seok, Lee, Han Ah, Kim, Mi Na, Lee, Yu Rim, Lee, Hye Won, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Hwang, Seong Gyu, Rim, Kyu Sung, Um, Soon Ho, Tak, Won Young, Kweon, Young Oh, Kim, Beom Kyung, Park, Soo Young

“…[Display omitted] •The hepatocellular carcinoma risk was not statistically different between the ETV and TDF groups.•The death or liver transplant risk was not…”
Get full text

Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model by Kim, Moon Young, Baik, Soon Koo, Park, Dong Hun, Jang, Yoon Ok, Suk, Ki Tae, Yea, Chang Jin, Lee, Il Young, Kim, Jae Woo, Kim, Hyun Soo, Kwon, Sang Ok, Cho, Mi Yun, Ko, Sang Baik, Chang, Sei Jin, Um, Soon Ho, Han, Kwang-Hyub

“…Background Angiotensin blockade such as with an angiotensin II receptor blocker (ARB) or angiotensinconverting enzyme inhibitor (ACEI) has antifibrotic…”
Get full text

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells by Lee, Young-Sun, Kim, So Yeon, Ko, Eunjung, Lee, Jun-Hee, Yi, Hyon-Seung, Yoo, Yang Jae, Je, Jihye, Suh, Sang Jun, Jung, Young Kul, Kim, Ji Hoon, Seo, Yeon Seok, Yim, Hyung Joon, Jeong, Won-Il, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

“…Non-alcoholic fatty liver disease (NAFLD) is a dominant cause of chronic liver disease, but the exact mechanism of progression from simple steatosis to…”
Get full text

Current management of hepatocellular carcinoma:An Eastern perspective by Yim, Hyung Joon, Suh, Sang Jun, Um, Soon Ho

“…Hepatocellular carcinoma(HCC) is one of the leading causes of cancer death, especially in Eastern areas. With advancements in diagnosis and treatment…”
Get full text

Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase by Lee, Han Ah, Lee, Hyun Woong, Kim, In Hee, Park, Soo Young, Sinn, Dong Hyun, Yu, Jung Hwan, Seo, Yeon Seok, Um, Soon Ho, Lee, Jung Il, Lee, Kwan Sik, Lee, Chang Hun, Tak, Won Young, Kweon, Young Oh, Kang, Wonseok, Paik, Yong‐Han, Lee, Jin‐Woo, Suh, Sang Jun, Jung, Young Kul, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang‐Hyub, Yim, Hyung Joon, Kim, Seung Up

“…Summary Background Anti‐viral therapy is not indicated for patients with chronic hepatitis B (CHB) in the immune‐tolerant phase. Aims To investigate the…”
Get full text

Determinants of re‐compensation in patients with hepatitis B virus‐related decompensated cirrhosis starting antiviral therapy by Kim, Tae Hyung, Um, Soon Ho, Lee, Young‐Sun, Yim, Sun Young, Jung, Young Kul, Seo, Yeon Seok, Kim, Ji Hoon, An, Hyunggin, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo

“…Summary Background Despite antiviral therapy, liver function often fails to recover in patients with hepatitis B virus (HBV)‐related decompensated cirrhosis…”
Get full text

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease by Kim, Tae Hyung, Lee, Yoonseok, Lee, Young-Sun, Gim, Jeong-An, Ko, Eunjung, Yim, Sun Young, Jung, Young Kul, Kang, SeongHee, Kim, Moon Young, Kim, Hayeon, Kim, Baek-hui, Kim, Ji Hoon, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

“…Nonalcoholic steatohepatitis (NASH) is considered as a progressive form of nonalcoholic fatty liver disease (NAFLD). To distinguish NASH from nonalcoholic…”
Get full text

Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma by Seo, Yeon Seok, Kim, Jin Nam, Keum, Bora, Park, Sanghoon, Kwon, Yong Dae, Kim, Yong Sik, Jeen, Yoon Tae, Chun, Hoon Jai, Kim, Chul Yong, Kim, Chang Duck, Ryu, Ho Sang, Um, Soon Ho

“…AIM： To evaluate the efficacy of radiotherapy （RT） in patients with advanced unresectable hepatocellular carcinoma （HCC）. METHODS： A total of 65 patients were…”
Get full text

Comparison of the characteristics of submucosal injection solutions used in endoscopic mucosal resection by Jin Hyun, Jong, Rae Chun, Hwang, Jai Chun, Hoon, Tae Jeen, Yoon, Won Baeck, Chang, Kyun Yu, Sang, Sik Kim, Yong, Sik Lee, Hong, Ho Um, Soon, Woo Lee, Sang, Hyun Choi, Jai, Duck Kim, Chang, Sang Ryu, Ho, Hai Hyun, Jin

“…Objective. Submucosal injection is used to prevent complications, such as perforation, during endoscopic mucosal resection (EMR). Since injection of normal…”
Get full text

Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy by Lee, Hyo-Suk, Yoo, Byung Chul, Lee, Kwan Sik, Kim, Ju Hyun, Um, Soon-Ho, Ryu, Soo Hyung, Lee, Young-Suk, Kim, Young Soo, Yoo, Kwon, Han, Joon-Yeol, Hwang, Jae Seok, Kim, Tae-Hun, Yang, Jin-Mo, Lee, Heon-Ju, Chon, Chae Yoon, Cho, Mong, Han, Byung Hoon, Hwang, Seong Gyu, Byun, Kwan Soo, Chung, Young-Hwa, Cho, Se-Hyun, Koh, Kwang Cheol, Kim, Byung-Ik, Kim, Haak Cheoul, Paik, Seung Woon, Lee, Myung-Seok, Yoo, Hee-Won, Han, Cheol Ju

“…Background This study was conducted to evaluate the durability of clevudine-induced viral response after the withdrawal of treatment. Methods Patients who…”
Get full text

Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial by Yim, Hyung Joon, Suh, Sang Jun, Jung, Young Kul, Yim, Sun Young, Seo, Yeon Seok, Lee, Yu Rim, Park, Soo Young, Jang, Jae Young, Kim, Young Seok, Kim, Hong Soo, Kim, Byung Ik, Um, Soon Ho

“…For the prevention of spontaneous bacterial peritonitis (SBP) in cirrhotic patients with ascites, norfloxacin 400 mg per day is recommended as a standard…”
Get full text